Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

Interim Management Statement

16 Nov 2017 07:00

RNS Number : 6332W
Macfarlane Group PLC
16 November 2017
 

 

Interim Management Statement

16 November 2017

 

Macfarlane Group PLC today provides an update on trading for the period from 30 June 2017 to 31 October 2017.

The momentum achieved in the first half of 2017 has continued in the second half of the year with improving organic growth and the continuing benefit from acquisitions. The Board is confident that its full year expectations will be met assuming that the Group benefits from the trading cycle in the final quarter of 2017 through our focus on the e-commerce sector.

Sales for the year to date in Packaging Distribution have increased by 11% and our recent acquisition, Greenwoods, is performing well in the final quarter of the year. Gross margins achieved are at similar levels to last year, reflecting the effective recovery of recent input price increases. Operating profit for the full year in Packaging Distribution is expected to be well above that achieved in 2016.

Combined sales from the businesses in our Manufacturing Operations are 3% below 2016, principally due to our continuing programme to focus on higher margin sales. Operating profit for the full year in the Manufacturing Operations is expected to be similar to 2016 levels.

The net effect of these factors is that Macfarlane Group's profit before tax for 2017 to date is well above the corresponding period in 2016 with a good contribution from acquisitions and this trend is expected to continue for the remainder of the year.

Bank borrowings of £14.6m at 30 June 2017 are expected to reduce by the end of the year, reflecting the Group's traditionally strong working capital inflows in the final quarter.

Stuart Paterson, Chairman of Macfarlane Group, said:

"I am pleased to report that Macfarlane Group's performance in the second half of 2017 has continued to reflect the good progress demonstrated in the first half. The Board remains confident that our full year expectations will be met."

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

 

Stuart Paterson Chairman

 

 

Peter Atkinson Chief Executive

 

 

John Love Finance Director

 

 

Spreng Thomson

Tel: 0141 548 5191

 

Callum Spreng

Mob: 07803 970103

 

LEI: 213800LVRYDERSJAAZ73

Notes to Editors:

· Macfarlane Group PLC is listed on the London Stock Exchange (LSE: MACF) in the Industrials Sector

· The company is headquartered in Glasgow, Scotland and has more than 60 years' experience in the UK packaging industry

· Macfarlane Group's businesses are:

o Macfarlane Packaging is the leading UK distributor of a comprehensive range of protective packaging products

o Labels designs and prints high quality self-adhesive and resealable labels, principally for FMCG companies

o Packaging Design and Manufacture designs and produces protective packaging for high value, fragile products

· Macfarlane Group employs over 850 people at 29 sites, principally in the UK, but also in Ireland and Sweden

The company has 20,000+ customers in the UK, Europe and the USA providing 600,000+ lines to a wide range of industry sectors including: consumer goods; food manufacturing; logistics; internet retail; mail order; electronics; defence and aerospace.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGGPGGUPMGMA
Date   Source Headline
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20217:00 amRNSNotice of AGM
6th Apr 20217:00 amRNSAnnual Report 2020
1st Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSDirector/PDMR Shareholding
4th Mar 20214:41 pmRNSSecond Price Monitoring Extn
4th Mar 20214:35 pmRNSPrice Monitoring Extension
4th Mar 20212:40 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAcquisition
25th Feb 20217:00 amRNSFinal Results
16th Feb 20217:00 amRNSNotice of Results
5th Feb 20217:00 amRNSAppointment of Sole Broker
14th Dec 20207:00 amRNSCompany Secretary Change
19th Nov 20207:01 amRNSBoard Changes
19th Nov 20207:00 amRNSTrading Update
5th Oct 20202:38 pmRNSDirector/PDMR Shareholding
15th Sep 202012:06 pmRNSHalf-year Report
2nd Sep 20201:00 pmRNSDirector/PDMR Shareholding
27th Aug 20207:00 amRNSHalf-year Report
6th Jul 20207:00 amRNSTrading Update
25th Jun 202012:08 pmRNSSecond Price Monitoring Extn
25th Jun 202012:03 pmRNSPrice Monitoring Extension
16th Jun 20203:59 pmRNSHolding(s) in Company
18th May 20204:35 pmRNSPrice Monitoring Extension
15th May 20209:30 amRNSChange of Company Secretary
13th May 20209:30 amRNSResult of AGM
12th May 202012:00 pmRNSAGM Statement
5th May 202010:00 amRNSDisclosure of rights attached to equity shares
9th Apr 20204:30 pmRNSNotice of AGM
6th Apr 20207:00 amRNSAnnual Report 2019
30th Mar 20207:00 amRNSCOVID-19 Trading Update
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn
13th Mar 20204:36 pmRNSPrice Monitoring Extension
2nd Mar 202012:08 pmRNSSecond Price Monitoring Extn
2nd Mar 202012:02 pmRNSPrice Monitoring Extension
27th Feb 20207:00 amRNSAnnual Results 2019
28th Jan 202010:00 amRNSNotice of Results
20th Nov 20197:00 amRNSTrading Update
11th Oct 20191:27 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSTotal Voting Rights
10th Sep 201911:28 amRNSHalf-year Report
2nd Sep 201912:00 pmRNSHolding(s) in Company
2nd Sep 20197:00 amRNSAcquisition
22nd Aug 20197:00 amRNSHalf-year Report
7th Aug 20198:02 amRNSNotice of Interim results
31st Jul 20197:46 amRNSHolding(s) in Company
31st May 20198:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.